XBP1 and cystic fibrosis: Inflammatory factors in CF patients can be regulated by the expression of XBP-1 in UPR, and AMs in CF patients can promote the occurrence of airway inflammation in CF patients by upregulating xBP-1-mediated cytokines (Zhu et al., 2012; Lubamba et al., 2015).